International Medical Center of Biomaterials Processing and Cryostorage (MOEX:GEMA)

Russia flag Russia · Delayed Price · Currency is RUB
672.00
-1.50 (-0.22%)
At close: Jul 8, 2022
-1.10%
Market Cap 10.03B
Revenue (ttm) 367.70M
Net Income (ttm) 151.14M
Shares Out 14.93M
EPS (ttm) 10.13
PE Ratio 66.35
Forward PE n/a
Dividend 8.65 (1.29%)
Ex-Dividend Date n/a
Volume 90
Average Volume 778
Open 666.00
Previous Close 673.50
Day's Range 666.00 - 674.00
52-Week Range 601.00 - 1,250.00
Beta 0.13
RSI 38.85
Earnings Date Mar 13, 2026

About MOEX:GEMA

International Medical Center of Biomaterials Processing and Cryostorage Public Joint-stock company operates as a personal stem cell storage bank in Russia. The company is also involved in the development of drugs for the treatment of blood and immune system diseases. It stores biomaterial samples, including samples of hematopoietic cord blood stem cells, as well as samples of mesenchymal stem cells and umbilical cord tissue for transplant. The company was founded in 2003 and is based in Moscow, Russia. International Medical Center of Biomateria... [Read more]

Industry Miscellaneous Health And Allied Services, Not Elsewhere Classified
Founded 2003
Employees 15
Stock Exchange Moscow Stock Exchange
Ticker Symbol GEMA
Full Company Profile

Financial Performance

In 2024, MOEX:GEMA's revenue was 348.60 million, an increase of 22.96% compared to the previous year's 283.51 million. Earnings were 151.22 million, an increase of 20.22%.

Financial Statements

News

There is no news available yet.